As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Following an international search, Professor Cristóbal Uauy has been appointed as the next Director of the John Innes Centre.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...